Avoro Capital Advisors LLC

Q1 2025 13F-HR Holdings

Location
New York, NY
Holdings as of
3/31/2025
Date filed
5/15/2025
Form type
13F-HR
Num holdings
33
Total value ($000)
$6,406,568
Net value change ($000)
-663,413 (-9.4%)
New positions
1
Sold out positions
7
Turnover %
4.3%
Sector allocation + QoQ delta (equities-only)
Prev filing: 2/14/2025 Next filing: 8/14/2025 SEC filing

Snapshot: Change Analysis

Compared to Q4 2024
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
BPMC 237,408 229.7%
ASND 110,739 15.8%
KRYS 80,568 19.6%
SLNO 66,912 59.0%
CNTA 58,239 NEW
MDGL 43,732 7.0%
Merus N.V. 36,914 41.3%
89bio, Inc. 14,103 44.0%
ALKERMES PLC 10,437 14.8%
RNAM 6,990 3.2%
Top Reduces (Value $000, Stocks/ETFs)
Intra-Cellular Therapies, Inc. -172,286 -67.6%
UTHR -149,322 -15.3%
SRPT -140,022 -45.1%
APLS -122,711 -31.5%
VERA -100,287 -42.3%
BMRN -96,130 -100.0%
ARWR -67,333 -32.2%
PCVX -58,426 -60.7%
FOLD -51,029 -23.4%
MLTX -41,773 -27.8%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type